-
-
Impact of SARS-CoV-2 interventions on dengue transmission
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Management of cases
Takeda1 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
Dengue: diagnosis and treatment updates
ISID62 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021